One plan - full access

No subscription, no auto-renewal, no hidden terms.
Pay once and use it for 30 days.

PRO plan No auto-renewal
$18

30 days of full access
One-time payment

🌐 US & Global Companies
Get access for 30 days →
♧ Secure payment · Instant access

What is included

  • ✓Full access to detailed company analysis
  • ✓Fundamental screener
  • ✓Advanced stock screener filters
  • ✓5 ratings. Separate lists for US & Global Companies and MOEX
  • ✓Company data export in XLSX and CSV
  • ✓MarketCap’s overall ranking of top companies
  • ✓Analytics updates after each new financial report
⚠ The service is not an investment advisor. Financial statement data from public companies is available to everyone - MarketCap structures and analyzes it.
ReWalk Robotics Ltd. logo
ReWalk Robotics Ltd. RWLK
report update icon

Quarterly report 2026-Q1
added 05-20-2026

ReWalk Robotics Ltd. Balance Sheet 2025-2011 | RWLK

Brief balance sheet overview of ReWalk Robotics Ltd.

The balance sheet is assessed across five available annual reports spanning 2021 to 2025.

Across five reporting periods, assets decreased -75.8%, from $94.8 million to $22.9 million, producing a negative trend.

Liabilities grew faster than assets: +170% versus -75.8%. A substantial part of expansion was externally funded.

Shareholders' equity accounts for 36.7% of assets, previously 94.3%. Dependence on liabilities is moderate.

The period ended with net cash: net debt stood at -$585 thousand. This supports financial flexibility.

The cash reserve occupies 9.5% of the balance sheet, previously 94%. It is one marker of short-term resilience.

Retained earnings remain negative at -$284.7 million. This may reflect past losses or substantial shareholder distributions, so earnings and buybacks provide important context.

Conclusion

ReWalk Robotics Ltd.'s balance sheet presents a mixed picture: strengths coexist with a limited cushion. Future capital and debt trends are particularly important.

Annual Balance Sheet ReWalk Robotics Ltd.

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-585 K -5.87 M -26.2 M -67 M -88 M -19.5 M -9.29 M -859 K 785 K -5.66 M -17.9 M -43.5 M -8.86 M -87 K -

Long Term Debt

1.16 M 22 K 607 K 333 K 418 K 923 K 1.53 M 6.96 M 8.91 M 10.5 M - - - - -

Long Term Debt Current

425 K 858 K 1.3 M 564 K 641 K 660 K 637 K 1.72 M 6.44 M 7.5 M - - - - -

Total Non Current Liabilities

2.45 M 1.41 M 4.89 M 1.29 M 1.33 M 1.62 M 3.42 M 7.64 M 9.43 M 11.1 M 311 K 238 K 3.52 M 2.25 M -

Total Current Liabilities

12 M 10.2 M 11.8 M 4.78 M 4.04 M 4.67 M 10.2 M 5.38 M 9.73 M 12.4 M 4.34 M 3.57 M - - -

Total Liabilities

14.5 M 11.6 M 16.7 M 6.07 M 5.37 M 6.29 M 13.6 M 13 M 19.2 M 23.5 M 4.65 M 3.81 M 5.43 M 4.36 M -

Deferred Revenue

920 K 1.25 M 1.5 M 301 K 316 K 441 K 323 K 237 K 123 K 54 K 199 K 77 K 198 K - -

Retained Earnings

-285 M -265 M -236 M -214 M -194 M -181 M -168 M -153 M -131 M -106 M -74 M -48.6 M -26.9 M -14.7 M -

Total Assets

22.9 M 30.5 M 63.2 M 74.2 M 94.8 M 28.1 M 24.4 M 15 M 22.9 M 31.8 M 25.6 M 47.7 M 11.1 M 2.09 M -

Cash and Cash Equivalents

2.17 M 6.75 M 28.1 M 67.9 M 89 M 21.1 M 16.3 M 9.55 M 14.6 M 23.7 M 17.9 M 41.8 M 8.86 M 769 K -

Book Value

8.41 M 18.8 M 46.5 M 68.2 M 89.4 M 21.8 M 10.8 M 1.94 M 3.71 M 8.26 M 20.9 M 43.9 M 5.63 M -2.26 M -

Total Shareholders Equity

8.41 M 18.8 M 46.5 M 68.2 M 89.4 M 21.8 M 10.8 M 1.94 M 3.71 M 8.26 M 20.9 M 43.9 M 5.63 M -2.26 M -

All numbers in USD currency

Quarterly Balance Sheet ReWalk Robotics Ltd.

2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

1.11 M 88 K 79 K 48 K 22 K 45 K 123 K 354 K 607 K 856 K 541 K 657 K 333 K 85 K 207 K 330 K 418 K 535 K 662 K 782 K 923 K 154 K 218 K 923 K 1.53 M 1.53 M 1.53 M 1.53 M 6.96 M 6.96 M 6.96 M 6.96 M 8.91 M 8.91 M 8.91 M 8.91 M 10.5 M 10.5 M 10.5 M 10.5 M - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

16.5 M 1.36 M 1.31 M 1.28 M 1.41 M 2.22 M 4.33 M 4.51 M 4.89 M 4.63 M 1.4 M 1.58 M 1.29 M 961 K 1.09 M 1.19 M 1.33 M 1.34 M 1.42 M 1.52 M 1.62 M 1.62 M 1.62 M 1.62 M 3.42 M 3.42 M 3.42 M 3.42 M 7.64 M 7.64 M 7.64 M 7.64 M 9.43 M 9.43 M 9.43 M 9.43 M 11.1 M 11.1 M 11.1 M 11.1 M 311 K 311 K 311 K 311 K 238 K - - - 3.52 M - - - - - - - - - - -

Total Liabilities

27.1 M 10.4 M 11.7 M 10.4 M 11.6 M 11.9 M 14.3 M 14.6 M 16.7 M 17.4 M 6.84 M 5.46 M 6.07 M 5.18 M 4.88 M 4.81 M 5.37 M 5.72 M 5.63 M 5.54 M 6.29 M 6.29 M 6.29 M 6.29 M 13.6 M 13.6 M 13.6 M 13.6 M 13 M 13 M 13 M 13 M 19.2 M 19.2 M 19.2 M 19.2 M 23.5 M 23.5 M 23.5 M 23.5 M 4.65 M 4.65 M 4.65 M 4.65 M 3.81 M - - - 5.43 M - - - - - - - - - - -

Deferred Revenue

966 K 1.16 M 1.17 M 1.33 M 1.25 M 1.36 M 1.39 M 1.43 M 1.5 M 1.61 M 435 K 357 K 301 K 369 K 335 K 323 K 316 K 353 K 330 K 388 K 441 K 441 K 441 K 441 K 323 K 323 K 323 K 323 K 237 K 237 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-296 M -279 M -276 M -270 M -265 M -250 M -246 M -242 M -236 M -230 M -223 M -218 M -214 M -208 M -203 M -199 M -194 M -190 M -188 M -185 M -181 M -181 M -181 M -181 M -168 M -168 M -168 M -168 M -153 M -153 M -153 M -153 M -131 M -131 M -131 M -131 M -106 M -106 M -106 M -106 M -74 M -74 M -74 M -74 M -48.6 M - - - -26.9 M - - - - - - - - - - -

Total Assets

33.4 M 23.2 M 26.8 M 28.8 M 30.5 M 45.8 M 51 M 55.2 M 63.2 M 69.2 M 65.8 M 69 M 74.2 M 80.8 M 85.8 M 90 M 94.8 M 98.7 M 71.7 M 74.6 M 28.1 M 28.1 M 28.1 M 28.1 M 24.4 M 24.4 M 24.4 M 24.4 M 15 M 15 M 15 M 15 M 22.9 M 22.9 M 22.9 M 22.9 M 31.8 M 31.8 M 31.8 M 31.8 M 25.6 M 25.6 M 25.6 M 25.6 M 47.7 M - - - 11.1 M - - - - - - - - - - -

Cash and Cash Equivalents

11.4 M 1.96 M 5.14 M 5.73 M 6.75 M 11 M 15.5 M 21.1 M 28.1 M 33.3 M 58.8 M 62.5 M 67.9 M 74.7 M 79.5 M 83.3 M 88.3 M 91.9 M 64.9 M 67.4 M 21.1 M 20.4 M 20.4 M 20.4 M 16.3 M 16.3 M 16.3 M 16.3 M 9.55 M 9.55 M 9.55 M 9.55 M 14.6 M 14.6 M 14.6 M 14.6 M 23.7 M 23.7 M 23.7 M 23.7 M 17.9 M 17.9 M 17.9 M 17.9 M 41.8 M - - - 8.86 M - - - 769 K - - - 559 K - - -

Book Value

6.29 M 12.8 M 15.1 M 18.5 M 18.8 M 33.9 M 36.7 M 40.6 M 46.5 M 51.8 M 59 M 63.5 M 68.2 M 75.6 M 80.9 M 85.2 M 89.4 M 93 M 66.1 M 69 M 21.8 M 21.8 M 21.8 M 21.8 M 10.8 M 10.8 M 10.8 M 10.8 M 1.94 M 1.94 M 1.94 M 1.94 M 3.71 M 3.71 M 3.71 M 3.71 M 8.26 M 8.26 M 8.26 M 8.26 M 20.9 M 20.9 M 20.9 M 20.9 M 43.9 M - - - 5.63 M - - - - - - - - - - -

Total Shareholders Equity

6.29 M 12.8 M 15.1 M 18.5 M 18.8 M 33.9 M 36.7 M 40.6 M 46.5 M 51.8 M 59 M 63.5 M 68.2 M 75.6 M 80.9 M 85.2 M 89.4 M 93 M 66.1 M 69 M 21.8 M 21.8 M 21.8 M 21.8 M 10.8 M 10.8 M 10.8 M 10.8 M 1.94 M 1.94 M 1.94 M 1.94 M 3.71 M 3.71 M 3.71 M 3.71 M 8.26 M 8.26 M 8.26 M 8.26 M 20.9 M 20.9 M 20.9 M 20.9 M 43.9 M - - - 5.63 M - - - -2.26 M - - - -829 K - - -

All numbers in USD currency

Balance Sheet is a fundamental financial report of ReWalk Robotics Ltd., providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Medical devices

Issuer Price % 24h Market Cap Country
Orthofix Medical Orthofix Medical
OFIX
$ 9.38 0.21 % $ 371 M curacaoCuracao
TransMedics Group TransMedics Group
TMDX
$ 70.78 1.32 % $ 2.41 B usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
$ 10.46 1.37 % $ 1.57 B usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 54.8 1.69 % $ 8.32 B usaUSA
Abbott Laboratories Abbott Laboratories
ABT
$ 104.89 0.19 % $ 183 B usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 4.11 34.31 % $ 256 M usaUSA
Nevro Corp. Nevro Corp.
NVRO
- - $ 217 M usaUSA
Electromed Electromed
ELMD
$ 27.42 0.07 % $ 227 M usaUSA
Establishment Labs Holdings Establishment Labs Holdings
ESTA
$ 59.18 0.15 % $ 1.75 B costa-ricaCosta-rica
Venus Concept Venus Concept
VERO
- - $ 726 K usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
Sientra Sientra
SIEN
- -16.59 % $ 10.3 M usaUSA
Silk Road Medical, Inc Silk Road Medical, Inc
SILK
- - $ 1.07 B usaUSA
Aethlon Medical Aethlon Medical
AEMD
$ 5.15 0.57 % $ 3.47 M usaUSA
Surgalign Holdings Surgalign Holdings
SRGA
- -32.98 % $ 1.68 M usaUSA
ShockWave Medical ShockWave Medical
SWAV
- - $ 12.3 B usaUSA
Abiomed Abiomed
ABMD
- - $ 17.2 B usaUSA
Titan Medical Titan Medical
TMDI
- -26.32 % $ 19.6 M canadaCanada
Natus Medical Incorporated Natus Medical Incorporated
NTUS
- 1.94 % $ 1.05 B usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Inari Medical Inari Medical
NARI
- - $ 4.23 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
$ 77.58 0.01 % $ 4.23 B britainBritain
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
NuVasive NuVasive
NUVA
- - $ 2.07 B usaUSA
LENSAR LENSAR
LNSR
$ 5.8 1.0 % $ 69.4 M usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
ThermoGenesis Holdings ThermoGenesis Holdings
THMO
- -25.84 % $ 171 K usaUSA
Talis Biomedical Corporation Talis Biomedical Corporation
TLIS
- 3.55 % $ 7.96 M usaUSA
Pulmonx Corporation Pulmonx Corporation
LUNG
$ 1.78 3.93 % $ 72.4 M usaUSA
Viveve Medical Viveve Medical
VIVE
- -15.35 % $ 1.71 M usaUSA
ViewRay ViewRay
VRAY
- 1.54 % $ 468 M usaUSA
SmileDirectClub SmileDirectClub
SDC
- -53.45 % $ 9.71 M usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Vapotherm Vapotherm
VAPO
- 6.72 % $ 34 M usaUSA
SeaSpine Holdings Corporation SeaSpine Holdings Corporation
SPNE
- 0.28 % $ 270 M usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
$ 0.16 3.22 % $ 19.6 M usaUSA
Zynex Zynex
ZYXI
- - $ 21.1 M usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Medigus Ltd. Medigus Ltd.
MDGS
- 10.28 % $ 55.5 M israelIsrael
Align Technology Align Technology
ALGN
$ 147.31 0.83 % $ 10.7 B usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
$ 2.55 0.39 % $ 105 M usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 44.39 0.53 % $ 65.7 B usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
$ 353.7 0.71 % $ 9.64 B usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 9.07 4.33 % $ 257 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
InspireMD InspireMD
NSPR
$ 0.46 0.29 % $ 29.6 M israelIsrael
Butterfly Network Butterfly Network
BFLY
$ 7.25 3.43 % $ 1.79 B usaUSA